Eton Pharmaceuticals Inc (ETON)
9.97
-0.49
(-4.68%)
USD |
NASDAQ |
Nov 15, 16:00
9.97
0.00 (0.00%)
After-Hours: 19:33
Eton Pharmaceuticals Research and Development Expense (Quarterly): 2.97M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.97M |
| March 31, 2024 | 0.651M |
| December 31, 2023 | 1.047M |
| September 30, 2023 | 0.615M |
| June 30, 2023 | 1.125M |
| March 31, 2023 | 0.535M |
| December 31, 2022 | 0.944M |
| September 30, 2022 | 0.744M |
| June 30, 2022 | 0.69M |
| March 31, 2022 | 1.618M |
| December 31, 2021 | 0.681M |
| September 30, 2021 | 2.678M |
| June 30, 2021 | 1.99M |
| March 31, 2021 | 0.886M |
| Date | Value |
|---|---|
| December 31, 2020 | 3.401M |
| September 30, 2020 | 2.826M |
| June 30, 2020 | 1.609M |
| March 31, 2020 | 6.268M |
| December 31, 2019 | 0.233M |
| September 30, 2019 | 3.418M |
| June 30, 2019 | 1.439M |
| March 31, 2019 | 6.465M |
| December 31, 2018 | 1.102M |
| September 30, 2018 | 1.544M |
| June 30, 2018 | 1.707M |
| March 31, 2018 | 1.274M |
| September 30, 2017 | 1.564M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.233M
Minimum
Dec 2019
6.268M
Maximum
Mar 2020
1.658M
Average
1.047M
Median
Dec 2023
Research and Development Expense (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 184.90M |
| Integra Lifesciences Holdings Corp | 27.44M |
| Elutia Inc | 1.001M |
| Immuneering Corp | 10.65M |
| Journey Medical Corp | 0.913M |